MSI1 and cancer: MSI-1 enhances therapeutic resistance by increasing the expression of DNA repair-associated proteins DNA-PKcs and EGFR, and therefore cancer treatment, in a way that identifies potential inhibitors of MSI proteins using high-throughput analysis [170].